Stimulating the growth of blood vessels in the brain through the use of fibroblast growth factor 1 (FGF1) may hold promise as a strategy for treating Parkinson’s disease, according to a white paper released by Zhittya Genesis Medicine (ZGM). Clinical trials testing this theory are being planned.
The white paper is titled “Parkinson’s Disease: Therapeutic Angiogenesis as a Disease Modifying, Breakthrough Therapy?”
It’s pretty difficult to believe it at this point, but there are still groups of Tesla critics who insist that Gigafactory 3 is not really fully operational. A central part of this thesis is the allegation that Gigafactory 3 does not have a stamping press, which means that Tesla’s China team is only assembling cars in the Shanghai-based factory using pre-stamped panels from Fremont.
A recently released video from Tesla China has just decimated these allegations in a subtle but definitive manner. The clip was short, less than 30 seconds long, but it showed a busy stamping press operating in Gigafactory 3. The video was released in China, and shared on Twitter by Tesla enthusiast @JayinShanghai.
In September 2015, as the Millennium Development Goals expired and the 2030 Agenda for Sustainable Development (link is external) was being adopted, USAID put forward an ambitious Vision for Ending Extreme Poverty.
Is information the fifth form of matter?
